Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures.
antiseizure medication
brivaracetam
focal seizures
seizure freedom
sodium channel blockers
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
06
03
2022
received:
13
02
2022
accepted:
09
03
2022
pubmed:
13
3
2022
medline:
10
5
2022
entrez:
12
3
2022
Statut:
ppublish
Résumé
The maintenance of seizure control over time is a clinical priority in patients with epilepsy. The aim of this study was to assess the sustained seizure frequency reduction with adjunctive brivaracetam (BRV) in real-world practice. Patients with focal epilepsy prescribed add-on BRV were identified. Study outcomes included sustained seizure freedom and sustained seizure response, defined as a 100% and a ≥50% reduction in baseline seizure frequency that continued without interruption and without BRV withdrawal through the 12-month follow-up. Nine hundred ninety-four patients with a median age of 45 (interquartile range = 32-56) years were included. During the 1-year study period, sustained seizure freedom was achieved by 142 (14.3%) patients, of whom 72 (50.7%) were seizure-free from Day 1 of BRV treatment. Sustained seizure freedom was maintained for ≥6, ≥9, and 12 months by 14.3%, 11.9%, and 7.2% of patients from the study cohort. Sustained seizure response was reached by 383 (38.5%) patients; 236 of 383 (61.6%) achieved sustained ≥50% reduction in seizure frequency by Day 1, 94 of 383 (24.5%) by Month 4, and 53 of 383 (13.8%) by Month 7 up to Month 12. Adjunctive BRV was associated with sustained seizure frequency reduction from the first day of treatment in a subset of patients with uncontrolled focal epilepsy.
Identifiants
pubmed: 35278335
doi: 10.1111/epi.17223
pmc: PMC9311068
doi:
Substances chimiques
Anticonvulsants
0
Pyrrolidinones
0
brivaracetam
U863JGG2IA
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e42-e50Investigateurs
Angela Alicino
(A)
Giovanni Assenza
(G)
Federica Avorio
(F)
Valeria Badioni
(V)
Paola Banfi
(P)
Emanuele Bartolini
(E)
Luca Manfredi Basili
(LM)
Vincenzo Belcastro
(V)
Simone Beretta
(S)
Irene Berto
(I)
Martina Biggi
(M)
Giuseppe Billo
(G)
Giovanni Boero
(G)
Paolo Bonanni
(P)
Jole Bongiorno
(J)
Francesco Brigo
(F)
Emanuele Caggia
(E)
Claudia Cagnetti
(C)
Carmen Calvello
(C)
Edward Cesnik
(E)
Gigliola Chianale
(G)
Domenico Ciampanelli
(D)
Roberta Ciuffini
(R)
Dario Cocito
(D)
Donato Colella
(D)
Margerita Contento
(M)
Cinzia Costa
(C)
Eduardo Cumbo
(E)
Alfredo D'Aniello
(A)
Francesco Deleo
(F)
Jacopo C DiFrancesco
(JC)
Roberta Di Giacomo
(R)
Alessandra Di Liberto
(A)
Elisabetta Domina
(E)
Francesco Donato
(F)
Fedele Dono
(F)
Vania Durante
(V)
Maurizio Elia
(M)
Anna Estraneo
(A)
Giacomo Evangelista
(G)
Maria Teresa Faedda
(MT)
Ylenia Failli
(Y)
Elisa Fallica
(E)
Jinane Fattouch
(J)
Alessandra Ferrari
(A)
Florinda Ferreri
(F)
Giacomo Fisco
(G)
Davide Fonti
(D)
Francesco Fortunato
(F)
Nicoletta Foschi
(N)
Teresa Francavilla
(T)
Rosita Galli
(R)
Sara Gasparini
(S)
Stefano Gazzina
(S)
Anna Teresa Giallonardo
(AT)
Filippo Sean Giorgi
(FS)
Loretta Giuliano
(L)
Francesco Habetswallner
(F)
Francesca Izzi
(F)
Benedetta Kassabian
(B)
Lorenzo Kiferle
(L)
Angelo Labate
(A)
Concetta Luisi
(C)
Matteo Magliani
(M)
Giulia Maira
(G)
Luisa Mari
(L)
Daniela Marino
(D)
Addolorata Mascia
(A)
Alessandra Mazzeo
(A)
Stefano Meletti
(S)
Chiara Milano
(C)
Annacarmen Nilo
(A)
Biagio Orlando
(B)
Francesco Paladin
(F)
Maria Grazia Pascarella
(MG)
Chiara Pastori
(C)
Giada Pauletto
(G)
Alessia Peretti
(A)
Gabriella Perri
(G)
Marianna Pezzella
(M)
Marta Piccioli
(M)
Pietro Pignatta
(P)
Nicola Pilolli
(N)
Francesco Pisani
(F)
Laura Rosa Pisani
(LR)
Fabio Placidi
(F)
Patrizia Pollicino
(P)
Vittoria Porcella
(V)
Monica Puligheddu
(M)
Stefano Quadri
(S)
Pier Paolo Quarato
(PP)
Rui Quintas
(R)
Rosaria Renna
(R)
Adriana Rum
(A)
Enrico Michele Salamone
(EM)
Ersilia Savastano
(E)
Maria Sessa
(M)
David Stokelj
(D)
Elena Tartara
(E)
Mario Tombini
(M)
Gemma Tumminelli
(G)
Anna Elisabetta Vaudano
(AE)
Ilaria Viganò
(I)
Emanuela Viglietta
(E)
Aglaia Vignoli
(A)
Flavio Villani
(F)
Elena Zambrelli
(E)
Lelia Zummo
(L)
Informations de copyright
© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Acta Neurol Scand. 2018 Jan;137(1):29-32
pubmed: 28741673
Epilepsy Res. 2016 Nov;127:114-118
pubmed: 27589414
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Acta Neurol Scand. 2020 Aug;142(2):91-107
pubmed: 32353166
Acta Neurol Scand. 2020 Aug;142(2):175-180
pubmed: 32432339
Epilepsia. 2021 Dec;62(12):2994-3004
pubmed: 34608628
Epilepsia. 2017 Feb;58(2):e21-e25
pubmed: 27988967
Epilepsia. 2017 Jul;58(7):1208-1216
pubmed: 28480518
Seizure. 2017 May;48:11-14
pubmed: 28364655
Epilepsia. 2022 May;63(5):e42-e50
pubmed: 35278335
Drugs Aging. 2021 Jul;38(7):603-610
pubmed: 34075567
Epilepsia. 2007 Jul;48(7):1303-7
pubmed: 17521343
Epilepsy Res. 2020 Sep;165:106329
pubmed: 32623096
Neurology. 2016 Jul 19;87(3):314-23
pubmed: 27335114
Drugs Aging. 2022 Apr;39(4):297-304
pubmed: 35344198
Neurology. 2016 Apr 5;86(14):1344-1352
pubmed: 26944275
Neurol Ther. 2019 Dec;8(2):491-504
pubmed: 31098888
CNS Drugs. 2021 Dec;35(12):1289-1301
pubmed: 34476770
Epilepsy Behav. 2020 May;106:106967
pubmed: 32179501
Epilepsia. 2021 Jan;62(1):e1-e6
pubmed: 33314118
Acta Neurol Scand. 2019 Apr;139(4):360-368
pubmed: 30506559
Epilepsy Res. 2017 Mar;131:70-75
pubmed: 28279891
Epilepsy Behav. 2020 Mar;104(Pt A):106939
pubmed: 32058303